SOURCE: Cutting Edge Information

September 16, 2008 08:18 ET

Latest Cutting Edge Information Study Examines Pharmaceutical Pricing Trends, Strategies and Processes

RESEARCH TRIANGLE PARK, NC--(Marketwire - September 16, 2008) - Pharmaceutical business intelligence firm Cutting Edge Information announces the launch of a new report centered on pharmaceutical pricing. "Outcomes-Based Pharmaceutical Pricing: Meeting Stakeholder Needs" examines trends, methodology and processes in pharmaceutical pricing. It focuses on pricing teams' challenges in satisfying various customer group demands and provides recommendations and strategies for improvement.

A report brochure is available for download here: http://cuttingedgeinfo.com/pharmapricingstrategy/index.htm#body

According to the report, deciding the price on a drug used to be a task set aside for later in the product development process. However, conflicting demands from various customer groups and unpredictable market dynamics are causing pharma pricing planning to be more strategic and integrated with other commercialization tasks. Pricing activities, like other marketing efforts, have been increasingly affected by globalization, and companies have adapted their strategies accordingly.

"Significant changes have taken place in the pharmaceutical pricing landscape since we conducted our previous pricing study a few years ago," said Haley Wynn, lead author of the report. "Pricing has gone from being an overlooked activity to being a crucial tool in lifecycle management."

The 124-page report provides an in-depth analysis of pharmaceutical pricing planning, processes, decision making and resources. Data are compiled from surveys and interviews with leading executives at over 30 global life sciences companies. Based on these findings and surveyed companies' best practices, CEI analysts offer action points to guide companies to set the right prices and optimize their profits.

The report contains 400+ metrics. Data focus on pricing teams' structures; phase-by-phase pricing processes and methodology; and spending and staffing resources. Metrics include the following:

--  Key internal stakeholders that influence pricing efforts
--  Resource support, innovative versus me-too drugs
--  Cross-functional involvement in pricing decisions
--  Share of companies with dedicated pricing departments
--  Lifecycle entry and exit points for functions involved in the pricing
    process
--  Effectiveness ratings for pricing study types
--  2008 pricing budgets and headcounts, by company size
--  2008 headcounts broken down by geographic market and by company size
    

Contact Information

  • CONTACT INFORMATION:

    For more information, contact:
    Haley Wynn
    Email Contact
    919-433-0224

    For media inquiries, contact:
    Lucas Einstein
    marketing specialist
    Email Contact
    919-433-0207